An FDA spokesperson told The Hill the considered strategy is because it is “clear to all of us that we would not meet current demand with the current supply.”
One manufacturer, Bavarian Nordic, is the only company in the world with an authorized monkeypox vaccine. The U.S. has bought more than a million doses to be shipped in batches through 2023, but multiple health systems and state departments have said they don’t have enough.
The shortage has forced online appointments to fill up within hours, hundreds of people to crowd blocks as they wait in line, and some of the hardest-hit cities have gone against FDA advisories by prioritizing the first dose as they wait for the next vaccine shipment.
The nation’s stockpile had more than 20 million Jynneos doses but they all expired before the current outbreak, which officials attributed to budget cuts.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
